News

The two new cast members announced for The Holy Grail of Eris anime are Yohei Azakami as Randolph Ulster and M.A.O as Lily Orlamunde. Their most recognizable prior roles are likely as Ron ...
Eris Lifesciences Limited on Thursday announced that it has appointed Murari Ranganathan as President, Cardiometabolic Business. He will be based out of the company’s Mumbai office and take char ...
We’re going to go over all of Eris’ abilities and how you should go about trying to counter these. Besides her moves, here are some tips to keep in mind for this fight. With all of these tips ...
Rock might be anathema to house-music purists, but that won’t stop Eris Drew dropping the needle on Led Zeppelin in one of the year’s most anticipated, and most fun, DJ sets. So I hope it’s ...
Biocon Biologics said that it has entered into a long-term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care ...
As part of the deal Biocon Biologics has signed a 10-year supply agreement with Eris, Biocon said in an exchange filing(Photo: Mint) Branded formulations company Eris ...
In Biocon’s continuing effort to divest and Eris Lifesciences’ attempt to grow, the companies have expanded a previous agreement, with Bangalore-based generics giant Biocon selling Indian ...
Eris Lifesciences has entered into a definitive agreement to acquire the India-branded formulation business of Biocon Biologics for ₹1,242 crore, a move that strengthens its footprint in the ...
The Eris Studio 8 is an excellent update with great low frequency delivery, and despite its size should work in rooms of all dimensions. No digital connectivity. MusicRadar's got your back Our team of ...
Indications come thanks to the capabilities of the Webb telescope, which was able to resolve differences in the hydrogen isotopes found on the chemicals that populate the surface of Eris and Makemake.
Indian pharma player Eris Lifesciences Ltd. said that the compay has expanded its sterile injectables footprint through the acquisition of 51 percent equity stake in Swiss Parenterals Ltd. for a ...
Eris Lifesciences Ltd has signed an agreement to acquire 51 per cent in Swiss Parenterals Limited (SPL), for ₹637.50 crore. The move bolsters Eris’ presence in the sterile injectables segment.